Boundless Bio Valuation
| BOLD Stock | USD 1.16 0.02 1.69% |
Today, the firm appears to be undervalued. Boundless Bio Common shows a prevailing Real Value of $1.6 per share. The current price of the firm is $1.16. Our model approximates the value of Boundless Bio Common from analyzing the firm fundamentals such as Return On Equity of -0.45, current valuation of (40.95 M), and Shares Owned By Insiders of 11.39 % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Boundless Bio's valuation include:
Undervalued
Today
Please note that Boundless Bio's price fluctuation is very risky at this time. Calculation of the real value of Boundless Bio Common is based on 3 months time horizon. Increasing Boundless Bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Boundless stock is determined by what a typical buyer is willing to pay for full or partial control of Boundless Bio Common. Since Boundless Bio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Boundless Stock. However, Boundless Bio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.16 | Real 1.6 | Target 3.0 | Hype 1.16 | Naive 1.15 |
The real value of Boundless Stock, also known as its intrinsic value, is the underlying worth of Boundless Bio Common Company, which is reflected in its stock price. It is based on Boundless Bio's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Boundless Bio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Boundless Bio Common helps investors to forecast how Boundless stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Boundless Bio more accurately as focusing exclusively on Boundless Bio's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Boundless Bio's intrinsic value based on its ongoing forecasts of Boundless Bio's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Boundless Bio's closest peers. If more than one evaluation category is relevant for Boundless Bio we suggest using both methods to arrive at a better estimate.
Boundless Bio Cash |
|
Boundless Bio Total Value Analysis
Boundless Bio Common is currently expected to have valuation of (40.95 M) with market capitalization of 26.42 M, debt of 47.63 M, and cash on hands of 351.46 M. The negative valuation of Boundless Bio may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Boundless Bio fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(40.95 M) | 26.42 M | 47.63 M | 351.46 M |
Boundless Bio Asset Utilization
One of the ways to look at asset utilization of Boundless is to check how much profit was generated for every dollar of assets it reports. Boundless Bio Common shows a negative utilization of assets of -0.25 percent, losing $0.002466 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Boundless Bio Common shows how discouraging it operates for each dollar spent on its assets.Boundless Bio Profitability Analysis
Considering Boundless Bio's profitability and operating efficiency indicators, Boundless Bio Common may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in March. Profitability indicators assess Boundless Bio's ability to earn profits and add value for shareholders.Net Loss | First Reported 2016-09-30 | Previous Quarter -15.7 M | Current Value -13.9 M | Quarterly Volatility 38.4 M |
For Boundless Bio profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Boundless Bio Common to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Boundless Bio utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Boundless Bio's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Boundless Bio over time as well as its relative position and ranking within its peers.
Boundless Bio Earnings per Share Projection vs Actual
By analyzing Boundless Bio's earnings estimates, investors can diagnose different trends across Boundless Bio's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Boundless Bio Common is based on EPS before non-recurring items and includes expenses related to employee stock options.Boundless Bio Ownership Allocation
Boundless Bio holds a total of 22.39 Million outstanding shares. Over half of Boundless Bio's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Boundless Bio Profitability Analysis
Net Loss for the year was (65.36 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Boundless Bio's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Boundless Bio and how it compares across the competition.
About Boundless Bio Valuation
The stock valuation mechanism determines Boundless Bio's current worth on a weekly basis. Our valuation model uses a comparative analysis of Boundless Bio. We calculate exposure to Boundless Bio's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Boundless Bio's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -977.4 K | -1 M |
Boundless Bio Current Valuation Indicators
Valuation refers to the process of determining the present value of Boundless Bio Common and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Boundless we look at many different elements of the entity such as Boundless's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Boundless Bio, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Boundless Bio's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Boundless Bio's worth.Complementary Tools for Boundless Stock analysis
When running Boundless Bio's price analysis, check to measure Boundless Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boundless Bio is operating at the current time. Most of Boundless Bio's value examination focuses on studying past and present price action to predict the probability of Boundless Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boundless Bio's price. Additionally, you may evaluate how the addition of Boundless Bio to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities |